RxDoctor Payments Data

Lauren Thomas, PA

Physician Assistant · Columbus, OHNPI 1104538495

Payments from drug & device makers

$654in general payments, 2019–2025

Across 13 payments — averaging $50.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$212
  • Exact Sciences$191
  • Lilly USA, LLC$121
  • Organon$47
  • Mannkind Corporation$27
  • Corcept Therapeutics$24
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$654100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654 in reported general payments places this provider in the 70th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$24,406
Medicare patients
91
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate30$36,437
MounjaroTirzepatide23$24,356
JardianceEmpagliflozin19$18,339
TrulicityDulaglutide12$11,526
ShingrixVaricella-Zoster Ge/As01b/Pf34$7,385
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,746
SynthroidLevothyroxine Sodium34$1,949
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$1,854
Rosuvastatin Calcium92$1,265
TenivacTetanus-Diphtheria Toxoids/Pf18$1,044
Atorvastatin Calcium138$951
Amlodipine Besylate180$760
Omeprazole42$746
Metoprolol Succinate59$630
Metformin Hcl ErMetformin Hcl68$503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$121$35,88135 claims
AbbVieSynthroid$13$1,94934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →